A subset of AML cases, especially those with monocytic features, may rarely exhibit a pDC-like immunophenotype with strong and homogeneous CD4, CD56 and CD123 expression, mimicking BPDCN [31,32,33]. The gene discussed is CD4; the disease is CD4+/CD56+ hematodermic neoplasm.